Efficacy of intravitreal triamcinolone for macular oedema due to CRVO after anti-androgen therapy for hirsutism in a young monocular female.
作者信息
Al-Dhibi Hassan, Chaudhry Imtiaz A, Al-Saati Annoud, Shamsi Farrukh A
出版信息
Br J Ophthalmol. 2007 Nov;91(11):1564-5. doi: 10.1136/bjo.2007.114843.
Abstract
摘要
相似文献
1
Efficacy of intravitreal triamcinolone for macular oedema due to CRVO after anti-androgen therapy for hirsutism in a young monocular female.
Br J Ophthalmol. 2007 Nov;91(11):1564-5. doi: 10.1136/bjo.2007.114843.
2
Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
Arch Ophthalmol. 2004 Aug;122(8):1131-6. doi: 10.1001/archopht.122.8.1131.
3
Macular oedema in central retinal vein occlusion treated with intravitreal triamcinolone.
Acta Ophthalmol Scand. 2006 Jun;84(3):314-8. doi: 10.1111/j.1600-0420.2005.00605.x.
4
Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion.
Br J Ophthalmol. 2004 Jan;88(1):154-5. doi: 10.1136/bjo.88.1.154.
5
Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion.
Br J Ophthalmol. 2002 Feb;86(2):247-8. doi: 10.1136/bjo.86.2.247.
6
Comparison of clinical efficacy of intravitreal ranibizumab with and without triamcinolone acetonide in macular edema secondary to central retinal vein occlusion.
Curr Eye Res. 2014 Sep;39(9):938-43. doi: 10.3109/02713683.2014.885533. Epub 2014 Mar 17.
7
Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema due to central retinal vein occlusion.
Eye (Lond). 2009 Dec;23(12):2215-22. doi: 10.1038/eye.2008.429.
8
Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion.
Acta Ophthalmol Scand. 2005 Feb;83(1):71-5. doi: 10.1111/j.1600-0420.2005.00400.x.
9
Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.
Retina. 2005 Oct-Nov;25(7):846-50. doi: 10.1097/00006982-200510000-00005.
10
Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion.
Am J Ophthalmol. 2005 May;139(5):860-6. doi: 10.1016/j.ajo.2005.01.001.
引用本文的文献
1
Optic neuritis secondary to antiandrogen therapy.
Ir J Med Sci. 2017 Aug;186(3):565-570. doi: 10.1007/s11845-016-1544-1. Epub 2016 Dec 30.
2
Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.
Cochrane Database Syst Rev. 2015 Sep 9;2015(9):CD007324. doi: 10.1002/14651858.CD007324.pub3.
3
Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.
Cochrane Database Syst Rev. 2009 Jan 21(1):CD007324. doi: 10.1002/14651858.CD007324.pub2.
本文引用的文献
1
[Central retinal vein occlusion in a patient treated with antiandrogenic drug].
J Fr Ophtalmol. 2000 Jan;23(1):42-4.
2
[Ocular complications of hormonal treatments: oral contraception and menopausal hormonal replacement therapy].
Contracept Fertil Sex. 1999 Apr;27(4):285-90.
3
Risk factors for central retinal vein occlusion. The Eye Disease Case-Control Study Group.
Arch Ophthalmol. 1996 May;114(5):545-54.
4
Central retinal vein occlusion in young adults.
Surv Ophthalmol. 1993 May-Jun;37(6):393-417. doi: 10.1016/0039-6257(93)90138-w.
5
Underlying medical conditions in young patients and ethnic differences in retinal vein occlusion.
Trans Ophthalmol Soc U K (1962). 1985;104 ( Pt 2):114-9.
6
Central retinal vascular occlusion associated with oral contraceptives.
Am J Ophthalmol. 1978 Dec;86(6):798-801. doi: 10.1016/0002-9394(78)90124-1.
Zotero 插件